Discovery of piperidine carboxamide TRPV1 antagonists

A series of piperidine carboxamides were developed as potent antagonists of the transient receptor potential receptor vanilloid 1 (TRPV1), an emerging target for the treatment of pain. A focused library of polar head groups led to the identification of a benzoxazinone amide that afforded good potenc...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry Vol. 18; no. 16; pp. 4569 - 4572
Main Authors Cheung, Wing S., Calvo, Raul R., Tounge, Brett A., Zhang, Sui-Po, Stone, Dennis R., Brandt, Michael R., Hutchinson, Tasha, Flores, Christopher M., Player, Mark R.
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 15.08.2008
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A series of piperidine carboxamides were developed as potent antagonists of the transient receptor potential receptor vanilloid 1 (TRPV1), an emerging target for the treatment of pain. A focused library of polar head groups led to the identification of a benzoxazinone amide that afforded good potency in cell-based assays. Synthesis and a QSAR model will be presented. A series of piperidine carboxamides were developed as potent antagonists of the transient receptor potential vanilloid-1 (TRPV1), an emerging target for the treatment of pain. A focused library of polar head groups led to the identification of a benzoxazinone amide that afforded good potency in cell-based assays. Synthesis and a QSAR model will be presented.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0960-894X
0968-0896
1464-3405
1464-3391
DOI:10.1016/j.bmcl.2008.07.035